Welcome
Support Centre
21 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ ...Back to search results ] [ Print-friendly version ]
Self Management supported by Assistive, Rehabilitation and Telecare Technologies
ISRCTN ISRCTN31254396
ClinicalTrials.gov identifier
Public title Self Management supported by Assistive, Rehabilitation and Telecare Technologies
Scientific title Multicentre non-randomised interventional process of care trial of self-management of chronic conditions supported by assistive, rehabilitation and telecare technology
Acronym SMART 2
Serial number at source 4912
Study hypothesis The overall aim of this project is to deepen understanding of the potential for technology support of self management. The use of technology for this purpose is now attracting attention, but there are some fundamental issues that need to be researched. These include how information on changes in chronic conditions can be collated and fed back to users in a meaningful and usable way to help them to understand their condition; how such information, remote from a clinician can be presented to promote behaviour change and how this information can allow people to adjust life goals to accommodate and aid acceptance of their condition.
Lay summary
Ethics approval Leeds East REC approved on the 3rd June 2008 (ref: 08/H1306/46)
Study design Multicentre non-randomised interventional process of care trial
Countries of recruitment United Kingdom
Disease/condition/study domain Topic: Generic Health Relevance and Cross Cutting Themes, Primary Care Research Network for England; Subtopic: Not Assigned, Generic Health Relevance (all Subtopics); Disease: All Diseases, Other
Participants - inclusion criteria User participants with one of the following conditions:
1. Stroke, congestive heart failure (CHF) and chronic pain
2. People with stroke - up to two years post stroke
3. People diagnosed with chronic heart failure (CHF) (New York Heart Association [NYHA]) 2, 3 or 4
4. Living in the community
5. Access to a telephone line
6. Sufficient English language skills in order to understand and express themselves verbally

Carer participants:
7. Co-resident with patient participant or in very frequent contact with them

Clinician participants:
8. Currently involved in delivery of services to people with one of the three conditions
Participants - exclusion criteria User participants:
1. Co-morbid cognitive or physical impairment to the extent that it will hinder participants from giving informed consent and/or talking in a group setting
2. In-patient in a hospital or other residential setting

Carer participants:
3. Not having a large amount of contact with a patient who has agreed to participate in the study
Anticipated start date 01/01/2008
Anticipated end date 31/12/2011
Status of trial Completed
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants Planned sample size: 150
Interventions A series of focus groups will be carried out during the first 3 - 6 months of the study. Home visits with up to five volunteer participants will take place after these focus groups (months 4 - 7). In year 2 and 3 we will undertake evaluation sessions at approximately 6-monthly intervals when elements of the PSMS will be delivered to the clinical research teams by technologists working at the University of Ulster. A series of focus groups, exclusively for clinicians specialising in treatment and rehabilitation of each of the three conditions will be conducted from month 6 onwards.
Primary outcome measure(s) To investigate how technology can be used to construct tailored plans of interventions to be undertaken
Secondary outcome measure(s) 1. To examine the extent to which behaviour change is promoted through personalised feedback
2. To identify how information on signs, symptoms and lifestyle consequences can be fed back to users in a usable way
3. To identify how relevant signs, symptoms and lifestyle consequences of long term conditions can be effectively monitored and modelled
Sources of funding Engineering and Physical Sciences Research Council (EPSRC) (UK)
Trial website
Publications
Contact name Prof  Mark  Hawley
  Address Health Services Research
School of Health & Related Research (ScHARR)
Regents Court
30 Regent Street
  City/town Sheffield
  Zip/Postcode S1 4DA
  Country United Kingdom
  Email mark.hawley@sheffield.ac.uk
Sponsor University of Sheffield (UK)
  Address Royal Hallamshire Hospital
Glossop Road
  City/town Sheffield
  Zip/Postcode S10 2JF
  Country United Kingdom
  Sponsor website: http://www.sheffield.ac.uk/
Date applied 18/06/2010
Last edited 12/11/2010
Date ISRCTN assigned 18/06/2010
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central